Otsu, Japan

Yuko Nakabayashi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Takara Bio Inc.. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Nakabayashi: Innovator in cDNA Synthesis

Introduction

Yuko Nakabayashi is a prominent inventor based in Otsu, Japan. She has made significant contributions to the field of genetic engineering, particularly through her innovative methods for synthesizing complementary DNA (cDNA). Her work has implications for various applications in biotechnology and molecular biology.

Latest Patents

Yuko Nakabayashi holds a patent for a method for synthesizing cDNA. This method is characterized by preparing a reaction solution that prevents endodeoxyribonuclease activity without the need for thermal deactivation or removal of the enzyme. The process involves a reverse transcription reaction using a treated sample that has undergone degradation of DNA, making it a valuable tool in genetic engineering.

Career Highlights

Throughout her career, Yuko has been associated with Takara Bio Inc., a company known for its advancements in biotechnology. Her innovative approach to cDNA synthesis has positioned her as a key figure in the field, contributing to the development of tools that enhance genetic research.

Collaborations

Yuko Nakabayashi has collaborated with notable colleagues, including Kiyozo Asada and Hiroyuki Mukai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of genetic engineering.

Conclusion

Yuko Nakabayashi's contributions to the field of cDNA synthesis exemplify her dedication to advancing genetic engineering. Her innovative methods and collaborations continue to influence the biotechnology landscape.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…